Sanofi’s AgomAb Therapeutics NV AGMB Stock Holding History
Bought
Maintained
Sold
Other funds holding AGMB
SL
Sanofi's AGMB Position: Q3 2026 in Review
Sanofi held its AgomAb Therapeutics NV (AGMB) position steady in Q3 2026 at 2,783,096 shares worth $30.9M. The position accounts for 4.9% of the portfolio, ranked #7.
Sanofi first reported a position in AGMB in Q1 2026 and has held it in 3 quarters since. The position peaked at $36.1M in Q2 2026. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.
- Sanofi held 2,783,096 shares of AgomAb Therapeutics NV worth $30.9M as of Q3 2026.
- Sanofi left its AgomAb Therapeutics NV share count unchanged in Q3 2026.
- AgomAb Therapeutics NV made up 4.9% of Sanofi's portfolio in Q3 2026, its #7 holding.
- Sanofi first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 3 quarters since.
- Sanofi's AgomAb Therapeutics NV position peaked at $36.1M in Q2 2026.
- 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.
Based on Sanofi's 13F filing for Q3 2026, filed 5 Nov 2026.